Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Psoriasis
Trial Locations (8)

100

National Taiwan University Hospital /ID# 230017, Taipei City

333

Linkou Chang Gung Memorial Hospital /ID# 253775, Taoyuan

704

National Cheng Kung University Hospital /ID# 253776, Tainan City

807

Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 230016, Kaohsiung City

11031

Taipei Medical University Hospital /ID# 230018, Taipei

30059

National Taiwan University Hospital - Hsinchu branch /ID# 238432, Hsinchu

40447

China Medical University Hospital /ID# 229961, Taichung

97002

Hualien Tzu Chi Hospital /ID# 238431, Hualien City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY